Search Videos and More
News
Targeted Drug Combination Shows Unprecedented Activity in Some Highly Aggressive Brain Tumors
Treatment with dabrafenib and trametinib yielded encouraging rate of durable responses in both high-grade and low-grade brain tumors carrying the rare BRAF v600E mutation. Study is first to show benefit of any targeted drugs in glioblastomas – the most aggressive brain tumor.
News
New Study Finds Link Between Patient Survival and Changes in Tumor Cell Mass in Brain Cancer
Researchers at Dana-Farber Cancer Institute and MIT have developed a new way to determine whether individual patients will respond to a specific cancer drug or not.
News
New Immunotherapy Target Discovered for Malignant Brain Tumors
Scientists say they have discovered a potential new target for immunotherapy of malignant brain tumors, which so far have resisted the ground-breaking cancer treatment based on harnessing the body’s immune system.